MEDIPOST, Teikoku Seiyaku partner for CARTISTEM commercialisation in Japan
MEDIPOST will supply drug substance and retain manufacturing rights, while exclusive rights for Japanese market will be managed by Teikoku Seiyaku.
Drug Manufacturers
Formycon and Zydus sign exclusive agreement for FYB206 supply
Denali makes $275m funding agreement with Royalty Pharma
Takeda and Innovent fulfil close conditions for ADC and IO therapies
Made Scientific and Cellergy partner to advance CLG-001
Moderna to onshore drug product manufacturing to Massachusetts
CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value
Chiesi and Aliada sign licence deal for enzyme replacement therapies
